Assessment of National Reporting of Drug-Resistant Streptococcus pneumoniae - United States, 1995-1996

Morbidity and Mortality Weekly Report

Volumn 45, Issue 43, 1996, Pages 947-949

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFECT; HEALTH SURVEY; HUMAN; INFECTION CONTROL; ISOLATION AND PURIFICATION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

DISEASE NOTIFICATION; DRUG RESISTANCE, MICROBIAL; HUMANS; PNEUMOCOCCAL INFECTIONS; POPULATION SURVEILLANCE; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

EID: 0030292434     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. CDC. Defining the public health impact of drug-resistant Streptococcus pneumoniae: report of a working group. MMWR 1996;45(no. RR-1).
2. CDC. National surveillance for infectious diseases, 1995. MMWR 1995;44:737-9.
3. Breiman RF, Butler JC, Tenover FC, Elliott JA, Facklam RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994;271:1831-5.
4. Reichler MR, Allphin AA, Breiman RF, et al. The spread of multiply-resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis 1992;166:1346-53.
5. Stool SE, Field MJ. The impact of otitis media. Pediatr Infect Dis J 1989;8:S11-S14.
6. Wenger JD, Hightower AW, Facklam RR, Gaventa S, Broome CV, the Bacterial Meningitis Study Group. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. J Infect Dis 1990;162:1316-23.
7. Martin SM, Bean NH. Data management issues for emerging diseases and new tools for managing surveillance and laboratory data. Emerging Infectious Diseases 1995;1:124-8.